Global availability of susceptibility testing for second-line anti-tuberculosis agents. Lazarchik A, Nyaruhirira AU, Chiang CY, Wares F, et al. Int J Tuberc Lung Dis 2022;26:524-528.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lazarchik A, Nyaruhirira AU, Chiang CY, Wares F, et al. Global availability of susceptibility testing for second-line anti-tuberculosis agents. Int J Tuberc Lung Dis 2022;26:524-528.
PMID: 35650708